Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (CPH.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CPH.TO · as of Jun 8, 2026
Key Statistics
Explore Cipher Pharmaceuticals Inc. Data
cph.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cph.to competitorsCPH.TO
ACB.TO
EDT.TO
FRX.TO
GUD.TO
HITI.VStock Performance
Full HistoryAbout Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for…
what is cipher pharmaceuticals inc. · cph.to stock overview · cipher pharmaceuticals inc. company profile · who is cipher pharmaceuticals inc. ceo · cph.to TSX · cipher pharmaceuticals inc. headquarters · cipher pharmaceuticals inc. business segments
About Stock Overview & Key Data
Cipher Pharmaceuticals Inc. (CPH.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since May 7, 2004. As of the latest trading session, CPH.TO stock price is $16.84, with a market capitalization of $427.6M. The stock has returned +31.87% over the past 12 months and +11.82% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cipher Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cipher Pharmaceuticals Inc. reported revenue of $51.3M and net income of $27.8M. For detailed data — including Cipher Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cipher Pharmaceuticals Inc. (CPH.TO) stock price is $16.84. The stock is traded on TSX under the ticker symbol CPH.TO. The 52-week range is $11.98 – $20.56.